2Williams MD, Nadle JL. Inflammatory mechanisms of dia - betic complications [J]. Curr Diab Rep,2007 ,7(3):242-248.
3Vileikyte L, Peyrot M, Gonzalez JS, et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longi- tudinalstudy[J]. Diabetologia,2009,52:1265-1273.
4Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: up- date on definitions,diagnontic criteria, estimation of severity, and treatments[J]. Diabetes Care,2010,33:2285-2293.
5Solomon Tesfaye. Advances in the management of diabetic periph- eral neuropathy [J]. Current Opinion in Supportive & Palliative Care, 2009,3(2):136-143.
6Tesfaye S,Boulton AJ. Diabetic Neuropathy[M]. Oxford: Oxford University Press,2009:34.
7KoIla VK, Madhavia G, Pulla Reddy B, et al. Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian pa- tients with type 2 diabetes[J]. Cytokine, 2009, 47(3):173-177.
8Drel VR, Lupachyk S, Shevalye H,et al. New therapeutic and biomarker discovery for peripheral diabetic neuropathy : PARP inhibitor, nitrotyrosine,and tumor necrosis factor-a[J]. En- docrinology ,2010,151(6):2547-2555.
9Winkler G, Kempler P. Pathomechanism of diabetic neuropathy: background of the pathogenesis - oriented therapy [J]. Orv Hetil, 2010,151(24):971-981.
10Brownlee M,Cameron NE,Gibson TM,et al. The unified patho- genesis of diabetes [J]. Ann NY Acad Sci,2005,1043:784-792.
